p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glaucoma is an age-related neurodegenerative disease of retinal ganglion cells, and appropriate turnover of the extracellular matrix in the trabecular meshwork is important in its pathology. Here, we report the effects of Rho-associated kinase (ROCK) and p38 MAP kinase on transforming growth factor (TGF)-β2-induced type I collagen production in human trabecular meshwork cells. TGF-β2 increased RhoA activity, actin polymerization, and myosin light chain 2 phosphorylation. These effects were significantly inhibited by Y-27632, but not SB203580. TGF-β2 also increased promoter activity, mRNA synthesis, and protein expression of COL1A2. These effects were significantly inhibited by SB203580, but not Y-27632. Additionally, Y-27632 did not significantly inhibit TGF-β2-induced promoter activation, or phosphorylation or nuclear translocation of Smad2/3, whereas SB203580 partially suppressed these processes. Collectively, TGF-β2-induced production of type 1 collagen is suppressed by p38 inhibition and accompanied by partial inactivation of Smad2/3, in human trabecular meshwork cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Collagen Type I upregulation has been shown to be suppressed by the p38 inhibitor SB203580 [ 118 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Retinal nerve fiber layer analysis in the diagnosis of glaucoma
Zangwill, L. M., & Bowd, C. (2006) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000193079.55240.18 · Cited by 595
Aqueous Humor in Glaucomatous Eyes Contains an Increased Level of TGF-β2
Tripathi, R. C., Li, J., Chan, W. A., & Tripathi, B. J. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1158 · Cited by 566
ARMALY, M. F. (1963) · Archives of Ophthalmology · doi:10.1001/archopht.1963.00960050484010 · Cited by 553 · cited 1×
“Armaly reported that the glucocorticoid dexamethasone (DEX) induces changes in IOP and fluid dynamics more frequently in glaucomatous than in normal eyes [33], [34].”
BackgroundExtracellular matrix in the trabecular meshwork
Acott, T. S., & Kelley, M. J. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.013 · Cited by 503 · cited 1×
“In this pathway, appropriate turnover of the extracellular matrix (ECM) in the TM is essential for maintaining normal outflow; excessive deposition of ECM increases the resistance to aqueous outflow [3], [4].”
BackgroundModulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao, P., Pf, D., Kumar, J., & Dl, E. (2001) · PubMed · Cited by 422
Honjo, M., Tanihara, H., Inatani, M., Kido, N., Sawamura, T., Yue, B. Y., Narumiya, S., & Honda, Y. (2001) · PubMed · Cited by 385
Self-citationTransforming growth factor-β2 levels in aqueous humor of glaucomatous eyes
Inatani, M., Tanihara, H., Katsuta, H., Honjo, M., Kido, N., & Honda, Y. (2001) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s004170000241 · Cited by 270
Self-citationEffects of TGF- 2 in Perfused Human Eyes
Gottanka, J. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0796 · Cited by 260 · cited 1×
“TGF-β2 increases the resistance in the aqueous humor outflow, via a mechanism involving deposition of ECM, including type 1 collagen, through changes in the actin cytoskeleton in the TM [5], [6], [7], [8], [9].”
Background
Cited by
Luo, L.-J., Nguyen, D. D., & Lai, J.-Y. (2021) · Theranostics · doi:10.7150/thno.54525 · Cited by 106
“Considering that TGF-β is a key modulator in altering the actin cytoskeleton of TM cells [51], we employed this growth factor to stimulate actin changes in TM cells and to investigate their response to Y-27632-loaded HMCNs with different shell”
BackgroundMethodTsai, C., Wu, S., Kau, H., & Wei, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-25370-3 · Cited by 82
Zhavoronkov, A. A., Izumchenko, E., Kanherkar, R. R., Teka, M., Cantor, C. R., Manaye, K. F., Sidransky, D., West, M. D., Makarev, E., & Csoka, A. B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170261 · Cited by 66
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Similarly, p38 has been reported to mediate the expression of extracellular matrix-related proteins in TGF-β stimulated TMCs. Collagen Type I upregulation has been shown to be suppressed by the p38 inhibitor SB203580 [118].”
BackgroundInfluentialLi, G., Lee, C.-Y., Read, A. T., Wang, K., Ha, J., Kuhn, M. N., Navarro, I. D., Cui, J., Young, K., Gorijavolu, R., et al. (2021) · eLife · doi:10.7554/elife.60831 · Cited by 65
Metadata
- Authors
- Inoue-Mochita, M., Inoue, T., Fujimoto, T., Kameda, T., Awai-Kasaoka, N., Ohtsu, N., Kimoto, K., & Tanihara, H.
- Affiliations
- Kumamoto University (JP)
- Kyoto University (JP)
- Oita University (JP)
- Corresponding author
- Inoue, Toshihiro
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-23
- Volume
- 10
- Issue
- 3
- Pages
- e0120774
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4370581
- OpenAlex
- W2135038084
- Cited by
- 34
- References
- 34
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 8 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 2
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (25861640, 23390403, 23791994)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p38 MAPK, Rho kinase, TGF-beta2, type I collagen, trabecular meshwork cells, glaucoma, extracellular matrix turnover, RhoA, actin polymerization, myosin light chain 2 phosphorylation, Smad2/3, COL1A2, Y-27632, SB203580
- MeSH terms
- Cell Line, Humans, Phosphorylation, Protein Binding, Trabecular Meshwork, Signal Transduction, Myosin Light Chains, Collagen Type I, Cardiac Myosins, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases, Smad Proteins, Transforming Growth Factor beta2, rho-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells. https://app.cochat.ai/papers/10.1371/journal.pone.0120774
- The paper
- Inoue-Mochita, M., Inoue, T., Fujimoto, T., Kameda, T., Awai-Kasaoka, N., Ohtsu, N., Kimoto, K., & Tanihara, H. (2015). p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-β2–Induced Type 1 Collagen Production in Trabecular Meshwork Cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0120774
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.